OTCMKTS:THERF

Theratechnologies (THERF) Stock Forecast, Price & News

$0.95

0.00 (0.00%)

(As of 05/31/2023 ET)

Compare

Today's Range: $0.86
▼
$0.96
50-Day Range: $0.78
▼
$1.01
52-Week Range: $3.58
▼
$7.29

Volume: 53,973 shs
Average Volume: 45,196 shs
Market Capitalization: $73.11 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Headlines

About Theratechnologies (OTCMKTS:THERF) Stock

Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.

Receive THERF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

THERF Stock News Headlines

May 12, 2023 | americanbankingnews.com

Theratechnologies (OTCMKTS:THERF) Stock Passes Above Fifty Day Moving Average of $0.88

October 13, 2021 | benzinga.com

Theratechnologies Q3 Earnings Lags Consensus As Trogarzo Sales Decline

June 1, 2023 | Vantage Point (Ad)

Major Financial Crisis Could Hit America

Something strange is happening in our financial system. UBS analysts predict over 50,000 retail locations may close soon. Retail giants like Walmart, Foot Locker, Bed Bath & Beyond, and Macy's are already downsizing their stores. Are you using the best technology to protect your money at all costs?

September 22, 2021 | feeds.benzinga.com

Theratechnologies' IV Push Form Of HIV Treatment At Par With IV Infusion

May 18, 2021 | gurufocus.com

Worth Venture Partners, LLC Buys Talend SA, Theratechnologies Inc, DZS Inc, Sells Blue Bird ...

May 18, 2021 | gurufocus.com

Soleus Capital Management, L.P. Buys Theratechnologies Inc, Krystal Biotech Inc, IVERIC bio ...

November 23, 2020 | financialpost.com

Theratechnologies to Present at the Piper Sandler Virtual Healthcare Conference

October 15, 2020 | fool.com

Theratechnologies Inc. (THTX) Q3 2020 Earnings Call Transcript

June 1, 2023 | Vantage Point (Ad)

Instantly Find Hidden Trade Opportunities

There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.

October 13, 2020 | feeds.benzinga.com

Theratechnologies Confirms Issuance of U.S. Patent Covering the Use of Tesamorelin in the Treatment of Individuals Suffering From NAFLD/NASH

October 8, 2019 | seekingalpha.com

Theratechnologies EPS beats by $0.02, misses on revenue

July 11, 2019 | seekingalpha.com

Theratechnologies Inc. (THERF) CEO Luc Tanguay on Q2 2019 Results - Earnings Call Transcript

July 11, 2019 | finance.yahoo.com

Theratechnologies, Inc. to Host Earnings Call

April 4, 2019 | seekingalpha.com

Theratechnologies Inc. (THERF) CEO Luc Tanguay on Q1 2019 Results - Earnings Call Transcript

March 21, 2019 | seekingalpha.com

Theratechnologies And NASH In HIV Patients, And The Market Assessment

March 14, 2019 | seekingalpha.com

Theratechnologies And Egrifta In NASH: A Hidden Gem With Broad Therapeutic Potential

February 22, 2019 | seekingalpha.com

Theratechnologies Inc. (THERF) CEO Luc Tanguay on Q4 2018 Results - Earnings Call Transcript

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive THERF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

THERF Company Calendar

Last Earnings: 4/04/2019
Today: 5/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:THERF
Previous Symbol: NASDAQ:THER
CUSIP: N/A
CIK: N/A
Web: www.theratech.com
Phone: 514-336-7800
Fax: N/A
Employees: 32
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.10)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-4,660,000.00
Net Margins: -11.57%
Pretax Margin: N/A
Return on Equity: -14.31%
Return on Assets: -4.25%

Debt

Debt-to-Equity Ratio: 1.70
Current Ratio: 2.69
Quick Ratio: 2.19

Sales & Book Value

Annual Sales: $45.18 million
Price / Sales: 1.62
Cash Flow: $0.01 per share
Price / Cash Flow: 177.07
Book Value: $0.47 per share
Price / Book: 2.02

Miscellaneous

Outstanding Shares: 76,953,000
Free Float: N/A
Market Cap: $73.11 million
Optionable: Not Optionable
Beta: 0.58

Key Executives

Mr. Luc Tanguay (Age 61)
Pres, CEO & Non-Independent Director

Mr. Philippe Dubuc MBA (Age 52)
Sr. VP & CFO

Mr. Jocelyn Lafond (Age 51)
VP of Legal Affairs & Corp. Sec.

Mr. Denis Boucher B.A. (Age 53)
L.L.B., VP of Communications & Corp. Affairs

Mr. Christian Marsolais (Age 56)
Sr. VP & Chief Medical Officer

Key Competitors

View All Competitors

THERF Stock - Frequently Asked Questions

How have THERF shares performed in 2023?: Theratechnologies' stock was trading at $0.8828 at the beginning of 2023. Since then, THERF shares have increased by 7.6% and is now trading at $0.95.
View the best growth stocks for 2023 here.
How were Theratechnologies' earnings last quarter?: Theratechnologies Inc (OTCMKTS:THERF) announced its earnings results on Thursday, April, 4th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.01. The company earned $15.10 million during the quarter. Theratechnologies had a negative net margin of 11.57% and a negative trailing twelve-month return on equity of 14.31%.
What is Theratechnologies' stock symbol?: Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF."

How do I buy shares of Theratechnologies?: Shares of THERF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Theratechnologies' stock price today?: One share of THERF stock can currently be purchased for approximately $0.95.
How much money does Theratechnologies make?: Theratechnologies (OTCMKTS:THERF) has a market capitalization of $73.11 million and generates $45.18 million in revenue each year. The company earns $-4,660,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.
How can I contact Theratechnologies?: Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The official website for the company is www.theratech.com. The company can be reached via phone at 514-336-7800 or via email at communications@theratech.com.

This page (OTCMKTS:THERF) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial